查看購物車
  • English
  • Japanese
核酸樣品製備設備市場－全球及區域分析：按產品類型、技術、處理能力、最終使用者和地區分類－分析與預測（2025-2035 年）
市場調查報告書
商品編碼
2019015

核酸樣品製備設備市場－全球及區域分析：按產品類型、技術、處理能力、最終使用者和地區分類－分析與預測（2025-2035 年）

Nucleic Acid Sample Preparation Instruments Market - A Global and Regional Analysis: Focus on Product Type, Technology, Throughput, End User, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 191 Pages | 商品交期: 1-5個工作天內

價格

2024 年全球核酸樣品製備設備市場初始估值為 9.101 億美元，但預計將大幅成長，到 2035 年將飆升至 16.018 億美元，並在 2025 年至 2035 年期間實現 5.10% 的顯著複合年成長率。

關鍵市場統計數據
預測期 2025-2035
2025年市場規模 9.743億美元
2035年預測 16.018億美元
複合年成長率 5.1%

在精準快速的分子診斷（尤其是感染疾病、腫瘤生物標記和遺傳疾病的檢測）需求不斷成長的推動下，該市場持續擴張。癌症、病毒感染和罕見遺感測染疾病等疾病負擔的日益加重，顯著加速了對高效核酸萃取和純化系統的需求，而這些系統是PCR和次世代定序（NGS）等下游應用的基礎。

成長要素之一是自動化和高通量核酸樣本製備設備的日益普及。這些設備透過最大限度地減少人工操作、降低人為誤差並確保結果的可重複性，從而提高了檢查室效率。檢查室正朝著整合提取、純化和分析的全流程工作流程發展，這縮短了檢測週轉時間，並實現了大規模檢測，尤其是在臨床和診斷領域。新冠疫情的經驗教訓進一步強化了這一趨勢，凸顯了可擴展且可靠的樣本製備技術的重要性。

此外，基因組學和個人化醫療的快速發展也顯著推動了市場成長。製藥和生物技術公司在研發領域投入巨資，其中核酸製備在生物標記發現、藥物研發和臨床試驗中發揮著至關重要的作用。次世代定序（NGS）、液態生物檢體和基因表現分析等技術的持續拓展應用，進一步推動了對能夠高精度處理複雜生物樣本的先進製備設備的需求。

此外，政府和私人部門對生命科學研究的投入增加，以及學術和研究機構的擴張，都在推動全球市場成長。在新興國家，由於醫療基礎設施的改善和人們對分子診斷意識的提高，分子診斷技術的應用也不斷普及。磁珠萃取、微流體技術和人工智慧自動化等技術創新，正在提升這些設備的效能和易用性，使其更容易被廣大終端使用者所接受。

市場概覽

近年來，全球核酸樣品製備設備市場經歷了顯著的變革，從傳統的手工萃取技術發展成為高度自動化、高通量系統，而這些系統對於現代分子生物學工作流程至關重要。這些儀器在從各種生物樣本中分離純化DNA和RNA方面發揮關鍵作用，為聚合酵素鏈鎖反應（PCR）、次世代定序（NGS）和基因表現分析等下游應用奠定了基礎。

市場發展的主要驅動力是精準診斷需求的不斷成長，尤其是在感染疾病檢測、腫瘤學和基因檢測等領域。隨著個人化醫療和標靶治療的推進，對可靠且高效的核酸製備技術的需求也日益凸顯。因此，臨床、科學研究和製藥領域的實驗室正擴大採用自動化解決方案，以提高準確性、可重複性和擴充性。

技術進步在塑造市場格局方面也發揮了至關重要的作用。磁珠萃取方法、微流體平台和整合式樣品到結果系統等創新技術顯著提高了工作流程效率，同時降低了污染風險並縮短了處理時間。此外，自動化和數位技術的融合實現了大批量樣品的無縫處理，使這些儀器在高通量環境中不可或缺。

此外，基因組研究的拓展，以及各國政府和私人機構投入的資金增加，正加速全球先進​​核酸樣本製備設備的應用。全球衛生危機期間的大規模檢測經驗，再次凸顯了穩健且擴充性的樣本製備解決方案的重要性，進一步推動了市場成長。總體而言，該市場正持續發展，成為診斷、生命科學研究和生物製藥開發領域創新發展的關鍵驅動力。

對產業的影響

全球核酸樣品製備設備市場正受到產業顯著影響，這主要得益於先進樣品製備技術在診斷、生命科學研究和生物製藥生產等領域的日益普及。核酸萃取和純化是分子工作流程的基礎，促使各產業迅速採用自動化設備，以提高營運效率、確保數據準確性並滿足大規模處理需求。這種轉變使實驗室和企業能夠簡化工作流程、縮短處理時間、最大限度地減少人為錯誤，並最終提高生產效率和成本效益。

在製藥和生物技術領域，這些儀器對於藥物發現、基因組研究和臨床試驗至關重要。精準醫療和標靶治療的日益普及顯著增加了對高品質核酸樣本的需求，直接推動了先進樣本製備系統的應用。此外，次世代定序（NGS）、液態生物檢體和生物標記分析的日益廣泛應用，進一步增強了對自動化和高通量解決方案的依賴，為儀器製造商開闢了新的成長途徑。

診斷產業正經歷重大變革，臨床檢查室擴大採用自動化核酸製備系統來處理大量檢測樣本並確保結果的一致性。這在傳染病檢查和腫瘤診斷領域尤其明顯，因為快速可靠的檢體處理至關重要。產業向一體化「檢體到結果」平台的轉型進一步提升了檢查室能力，並推動了分散式檢查模式的發展。

此外，核酸樣本製備設備市場正在影響整個檢查室自動化生態系統，推動機器人流體處理系統、微流體平台和人工智慧資料管理工具等配套技術的發展。製造商正致力於創新、策略合作和產品差異化，以滿足不斷變化的產業需求。因此，核酸樣本製備設備市場不僅支持醫學和研究的進步，而且推動整個生命科學價值鏈的自動化、擴充性和技術整合，從而重塑行業實踐。

市場區隔:

細分 1：按產品類型

  • 核酸萃取系統
  • 樣品破碎均質裝置
  • 液體處理和自動化系統

預計核酸萃取系統細分市場將推動核酸樣品製備設備市場（按產品類型分類）的發展。

按產品類型分類，核酸萃取系統預計將成為核酸樣品製備設備市場的主要驅動力，因為它在分離下游分子應用所需的高品質DNA和RNA方面發揮著至關重要的作用。這些系統是PCR、次世代定序（NGS）和基因表現分析等工作流程中至關重要的第一步，並且已成為臨床診斷、實驗室、製藥和生物技術產業不可或缺的工具。

該領域的領先地位主要源自於對自動化、高通量提取解決方案日益成長的需求，這些方案需確保準確性、可重複性和無污染處理。隨著感染疾病、癌症和遺傳性疾病的日益流行，實驗室正優先採用能夠處理包括血液、組織和唾液在內的多種樣本類型的可靠萃取系統。此外，磁珠萃取和自動化純化平台等技術的進步顯著提高了效率並減少了人工干預，進一步加速了這些技術的應用。

此外，隨著分子診斷和基因組學研究的拓展，對能夠處理大量樣本且不影響品質的高擴充性提取系統的需求日益成長。製藥和生物技術公司也透過在藥物研發、生物標記鑑定和臨床試驗中廣泛應用這些系統，推動了該領域的成長。隨著實驗室朝向整合化和自動化工作流程發展，核酸萃取系統作為確保下游分析流程可靠性和成功率的關鍵因素，預計將繼續保持其主導地位。

第二類細分：依技術

  • 自動化旋轉柱系統
  • 磁珠以微珠為基礎
  • 自動化液體處理

在核酸樣品製備設備市場（按技術分類），磁珠法有望成為主導技術。

由於以微珠為基礎技術具有卓越的效率、擴充性和與自動化工作流程的兼容性，預計將在核酸樣品製備設備市場佔據主導地位。此方法是核酸萃取和純化的首選，因為它能夠在包括血液、組織和複雜生物體液在內的多種樣本類型中實現高產量和高純度的DNA和RNA萃取。

分子診斷和基因組研究領域對高通量、無污染處理的需求日益成長，這是推動以微珠為基礎應用的主要動力。與傳統的柱式或手動萃取技術不同，磁珠技術能夠實現無縫自動化，縮短處理時間，並最大限度地降低交叉污染的風險，使其成為臨床檢查室和大規模檢測環境的理想選擇。這在準確性和可重複性至關重要的應用中尤其重要，例如次世代定序(NGS)、PCR 和微量殘存疾病(MRD) 檢測。

此外，磁珠通訊協定的柔軟性使其能夠輕鬆整合到機器人液體處理系統和全自動平台中，從而進一步提高檢查室效率。製藥和生物技術公司正擴大將這項技術應用於藥物發現、生物標記研究和臨床試驗，推動了其廣泛應用。磁珠化學性質和自動化能力的不斷進步，進一步提升了其性能並擴展了應用範圍。

隨著實驗室不斷優先考慮速度、精確性和擴充性，磁珠技術有望保持主導地位，這得益於其與持續向自動化和先進分子工作流程轉變的緊密親和性。

細分3：依處理能力分類

  • 低吞吐量設備
  • 中等通量設備
  • 高通量設備

在核酸樣品製備設備市場（按處理能力分類），中等處理能力的設備預計將成為主流。

中等通量設備預計將憑藉其高通量優勢，成為核酸樣本製備設備市場的主要驅動力，因為它在處理能力、成本效益和操作柔軟性之間實現了最佳平衡。這些系統尤其適用於中型實驗室、診斷中心和研究機構，它們需要穩定的樣本處理，但又不想像大規模高通量平台那樣投入巨額資金。

此細分市場的優勢源自於分子診斷領域對高效、擴充性解決方案日益成長的需求，尤其是在傳染病檢查、腫瘤診斷和基因分析等應用領域。中等通量儀器通常處理適中的樣本量，因此非常適合日常實驗室工作流程，因為在這些流程中，準確性、可重複性和周轉時間至關重要。它們能夠在不影響效能的前提下處理不同的樣本負載量，因此成為各類終端使用者的首選。

此外，檢查室自動化程度的不斷提高也推動了對中等通量系統的需求。這些系統通常具有方便用戶使用的介面和整合的通訊協定，並且兼容磁珠法等先進的提取技術。這些特性減少了人工干預，最大限度地降低了誤差，並提高了檢查室的整體效率。

製藥和生物技術公司以及學術和研究機構正透過使用中等通量儀器進行藥物發現、生物標記研究和臨床試驗檢體處理等應用，推動這一領域的成長。隨著實驗室對能夠適應不斷變化的檢測需求且經濟高效、用途廣泛的解決方案的需求持續成長，中等通量儀器有望繼續保持主導地位。

細分 4：按最終用戶

  • 學術研究機構
  • 製藥和生物技術公司
  • 臨床診斷中心
  • 應用測試（生物樣本庫、法醫學和獸醫研究所）
  • 受託研究機構

核酸樣品製備設備市場（按最終用戶分類）預計將由學術研究機構主導。

學術研究機構預計將成為核酸樣品製備設備終端使用者市場的主要驅動力，這主要得益於它們在基因組研究、分子生物學研究和早期科學發現領域的廣泛參與。這些機構是重要的創新中心，核酸萃取和純化已成為基因表現分析、次世代定序(NGS) 和功能基因體學等眾多應用領域不可或缺的關鍵步驟。

政府和私人機構對生命科學研究的大力投入是推動該領域發展的主要因素。大學和研究中心正不斷增加對先進實驗室基礎設施的投資，包括自動化核酸樣本製備設備，以提高研究效率並確保獲得高品質、可重複的結果。此外，對癌症研究、感染疾病和遺傳疾病等領域的日益關注，也擴大了學術機構對可靠樣本製備技術的需求。

學術機構在大規模合作計劃和聯盟研究中發揮著至關重要的作用，這些計畫和研究通常需要處理大量的生物樣本。這促使人們採用能夠處理各種複雜工作流程的中高通量儀器。此外，學術機構與製藥和生物技術公司之間的合作有助於技術轉移，並加速先進核酸製備解決方案的應用。

隨著基因組學的不斷進步和精準醫療的日益普及，學術研究機構預計仍將是主要的終端使用者群體。它們持續的研究活動、創新以及對尖端實驗室技術的需求將顯著推動市場成長。

細分5：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 波蘭
    • 葡萄牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 韓國
    • 泰國
    • 台灣
    • 新加坡
    • 印尼
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 智利
    • 墨西哥
    • 哥倫比亞
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

從區域來看，北美在核酸樣品製備設備市場處於領先地位。

從區域來看，北美預計將成為核酸樣本製備設備市場的主要驅動力。這主要得益於其完善的醫療保健基礎設施、許多大型生物技術和製藥公司的強大影響力，以及先進分子診斷技術的高度普及。該地區，尤其是美國，是全球基因組研究和精準醫療的中心，極大地推動了對高效自動化核酸製備系統的需求。

該地區佔據主導地位的主要因素是政府機構和私營組織對研發的大量投入。來自美國國立衛生研究院 (NIH) 等機構的資助，以及業內企業的持續創新，正在加速先進實驗室自動化解決方案的普及應用。此外，慢性病、癌症和感染疾病的日益流行，進一步增加了對可靠分子檢測的需求，從而推動了對核酸樣本製備設備的需求。

北美地區也受惠於早期採用的最尖端科技，例如次世代定序(NGS)、基於 PCR 的診斷方法和自動化流體處理系統。主要市場參與者的存在、頻繁的產品發布、合作研究和戰略夥伴關係進一步鞏固了該地區的領先地位。此外，隨著人們的關注點轉向個人化醫療和基於生物標記的療法，對高品質核酸萃取和純化過程的依賴性也日益增強。

此外，該地區強大的臨床和研究生態系統，包括學術機構、診斷檢查室和生物製藥公司，確保了對這些設備的持續需求。有利的法規結構以及對品質和標準化的高度重視也促進了這些設備的廣泛應用。因此，預計北美將在整個預測期內保持其在全球核酸樣本製備設備市場的主導地位。

核酸樣品製備設備市場最新趨勢

  • 2025年10月，AutoGen公司與Sampled公司合作，開始提供新一代核酸萃取和多組體學工作流程。根據該協議，Sampled公司將把複雜的提取計劃轉介給AutoGen公司，而AutoGen公司將把大規模提取和下游分析委託給Sampled公司的一體化化驗服務。
  • 2025 年 4 月，QIAGEN NV 宣布計畫在 2025 年至 2026 年間推出三款新的樣品製備系統（QIAsymphony Connect、QIAsprint 和 QIAmini），以提高實驗室各環節的自動化程度和效率。

需求——促進因素、挑戰與機遇

市場促進因素：

分子診斷和基因組檢測需求的不斷成長正在推動核酸樣本製備設備市場的發展。為了滿足日益成長的分子檢測需求，公共衛生機構和臨床檢查室正優先採用自動化且可重複的樣本製備平台。隨著檢測數量的持續增加，專注於提高提取效率、處理能力以及與下游工作流程整合度的設備製造商將更有利於擴大市場佔有率。

市場挑戰

高成本－成本障礙不僅是價格問題，更是影響公共和私人醫療系統採購決策的市場准入挑戰。為了擴大核酸樣本製備技術的應用，設備製造商可能需要開發創新的定價策略、模組化系統方案或資金籌措合作模式，特別要關注公共衛生檢查室和中低收入地區。解決設備價格可負擔性問題能夠刺激潛在需求，從而加速分子檢測基礎設施的現代化，並促進全球更公平地獲取先進診斷技術。

市場機遇

自動化和整合工作流程—核酸樣品製備儀器製造商需要不斷創新並整合工作流程，以擴大儀器的應用範圍，尤其是在高通量、臨床和實驗室環境中。隨著分子診斷需求的持續成長，能夠提供無縫、可重複且可擴展的樣品製備工作流程的平台，將透過解決週轉時間、品管和營運成本效益等關鍵檢查室挑戰而脫穎而出。

這份報告將為貴公司帶來哪些附加價值？

產品與創新策略－全球核酸樣本製備設備市場細分為多個關鍵部分，包括產品類型、技術、處理能力、終端使用者和區域市場。透過了解哪些細分市場佔據最大的市場佔有率以及哪些細分市場具有成長潛力，本報告為旨在創新產品和擴展產品組合的企業提供了寶貴的見解。

成長與行銷策略：策略夥伴關係、夥伴關係和業務擴張預計將在核酸樣本製備設備市場的成長中發揮核心作用。診斷公司、醫療服務提供者和研究機構之間的關鍵發展和合作已經開始成為市場動態的重要組成部分。

競爭策略：核酸樣品製備設備市場競爭異常激烈，Thermo Fisher Scientific Inc.、QIAGEN NV、F. Hoffmann-La Roche AG、Danaher Corporation 和 Agilent Technologies, Inc. 等主要企業憑藉強大的產品系列和持續創新引領市場。各公司均致力於自動化、先進的提取技術和策略聯盟，以提高效率並擴大市場影響，從而創造出充滿活力且創新主導的市場環境。

調查方法

市場設計與檢驗的關鍵考量與假設

  • 對於全球市場規模估算，涵蓋的期間為 2024 年至 2035 年，其中 2024 年為基準年，2025 年至 2035 年為預測期。
  • 本報告的範圍是基於來自各行業的專家提供的全面信息，包括專科診所、醫院、診斷檢查室、參考檢查室和研究機構。
  • 核酸樣品製備設備的市場佔有率預計未來將大幅成長，這一預測是基於對現有解決方案歷史數據的分析得出的。
  • 每家公司的企業獲利均根據其2024年年度報告計算。對於私人公司，企業獲利估算則來自一手調查數據、資金籌措歷史、市場合作關係和業務表現。
  • 本報告基於現有的核酸樣本製備設備、市場產品和服務，對市場進行了分析。報告還識別並介紹了該領域提供關鍵產品和服務的主要企業。

主要市場參與企業及競爭格局概述

本報告中介紹的公司簡介是根據對每家公司的業務範圍、產品系列和市場滲透率的分析而選擇的。

該市場的主要企業包括以下幾家：

  • F. Hoffmann-La Roche AG
  • Promega Corporation
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • Eppendorf
  • Macherey-Nagel GmbH & Co. KG
  • Sage Science, Inc.
  • Hamilton Company
  • Revvity, Inc. (PerkinElmer, Inc.)
  • AutoGen Inc.
  • Hain Lifescience GmbH / BRUKER
  • bioMerieux, Inc.
  • Aurora Biomed Inc.
  • Genetic Signatures
  • Bioteke Corporation

目錄

執行摘要

第1章 市場：產業展望

  • 市場概覽與生態系統
  • 市場吸引力：宏觀與微觀因素分析
  • 監理展望
  • 價格分析

第2章：全球核酸樣品製備設備市場概覽

  • 商業動態
    • 影響分析
    • 市場促進因素
    • 市場限制因素
    • 市場機會與趨勢

第3章：2024-2035年全球核酸樣品製備設備市場（依產品類型分類）

  • 概述
  • 成長佔有率矩陣
  • 核酸萃取系統
  • 樣品破碎均質裝置
  • 液體處理和自動化系統

第4章：2024-2035年全球核酸樣品製備設備市場（依技術分類）

  • 概述
  • 成長佔有率矩陣
  • 自動旋轉柱底座
  • 利用磁珠提高磁通量
  • 自動化液體處理

第5章：2024-2035年全球核酸樣品製備設備市場（依吞吐量分類）

  • 概述
  • 成長佔有率矩陣
  • 低吞吐量設備
  • 中等通量設備
  • 高通量設備

第6章：2024-2035年全球核酸樣品製備設備市場（依最終使用者分類）

  • 概述
  • 成長佔有率矩陣
  • 學術研究機構
  • 製藥和生物技術公司
  • 臨床診斷中心
  • 應用檢測（生物樣本庫、法醫學研究所、獸醫研究所）
  • 受託研究機構

第7章 區域

  • 區域概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 市場－競爭標竿分析與公司概況

  • 產品基準測試
  • 關鍵策略和企業發展（按公司分類）
  • 企業市場占有率分析
  • 公司簡介
    • F. Hoffmann-La Roche AG
    • Promega Corporation
    • QIAGEN NV
    • Thermo Fisher Scientific Inc.
    • Tecan Trading AG
    • Eppendorf
    • Macherey-Nagel GmbH & Co. KG
    • Sage Science, Inc.
    • Hamilton Company
    • Revvity, Inc. (PerkinElmer, Inc.)
    • AutoGen Inc.
    • Hain Lifescience GmbH/BRUKER
    • bioMerieux, Inc
    • Aurora Biomed Inc.
    • Genetic Signatures
    • Bioteke Corporation

第9章：調查方法

Product Code: BHL3509SA

This report can be delivered within 1 working day.

Introduction of the Nucleic Acid Sample Preparation Instruments Market

The global nucleic acid sample preparation instruments market, initially valued at $910.1 million in 2024, is projected to witness substantial growth, surging to $1,601.8 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 5.10% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$974.3 Million
2035 Forecast$1,601.8 Million
CAGR5.1%

The market is experiencing sustained expansion, driven by the increasing demand for accurate and rapid molecular diagnostics, particularly in the detection of infectious diseases, oncology biomarkers, and genetic disorders. The growing burden of conditions such as cancer, viral infections, and rare genetic diseases has significantly accelerated the need for efficient nucleic acid extraction and purification systems, which form the foundation of downstream applications like PCR and next-generation sequencing (NGS).

A key growth driver is the rising adoption of automated and high-throughput nucleic acid sample preparation instruments, which enhance laboratory efficiency by minimizing manual intervention, reducing human error, and ensuring reproducibility of results. Laboratories are increasingly transitioning toward fully integrated workflows that combine extraction, purification, and analysis, thereby improving turnaround times and enabling large-scale testing, especially in clinical and diagnostic settings. This trend has been further reinforced by the lessons learned during the COVID-19 pandemic, which highlighted the critical importance of scalable and reliable sample preparation technologies.

Moreover, the rapid advancements in genomics and personalized medicine are contributing significantly to market growth. Pharmaceutical and biotechnology companies are investing heavily in research and development activities, where nucleic acid preparation plays a crucial role in biomarker discovery, drug development, and clinical trials. The expanding applications of NGS, liquid biopsy, and gene expression analysis are further boosting demand for advanced preparation instruments capable of handling complex biological samples with high precision.

In addition, increasing government funding and private investments in life sciences research, along with the expansion of academic and research institutes, are supporting market growth globally. Emerging economies are also witnessing rising adoption due to improving healthcare infrastructure and growing awareness of molecular diagnostics. Technological innovations, such as magnetic bead-based extraction, microfluidics, and AI-enabled automation, are enhancing the performance and usability of these instruments, making them more accessible across diverse end users.

Market Introduction

The global nucleic acid sample preparation instruments market has undergone a significant transformation in recent years, evolving from conventional manual extraction techniques to highly automated, high-throughput systems that are integral to modern molecular biology workflows. These instruments play a critical role in the isolation and purification of DNA and RNA from a wide range of biological samples, forming the foundation for downstream applications such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and gene expression analysis.

The market's evolution has been largely driven by the growing demand for precision diagnostics, particularly in areas such as infectious disease detection, oncology, and genetic testing. The increasing shift toward personalized medicine and targeted therapies has further emphasized the need for reliable and efficient nucleic acid preparation technologies. As a result, laboratories across clinical, research, and pharmaceutical settings are increasingly adopting automated solutions that offer improved accuracy, reproducibility, and scalability.

Technological advancements have also played a pivotal role in shaping the market landscape. Innovations such as magnetic bead-based extraction methods, microfluidic platforms, and integrated sample-to-result systems have significantly enhanced workflow efficiency while reducing contamination risks and processing time. Additionally, the integration of automation and digital technologies has enabled seamless handling of large sample volumes, making these instruments indispensable in high-throughput environments.

Furthermore, the expansion of genomics research, coupled with increased funding from governments and private organizations, has accelerated the adoption of advanced nucleic acid sample preparation instruments globally. The experience of large-scale testing during global health crises has reinforced the importance of robust and scalable sample preparation solutions, further driving market growth. Overall, the market continues to advance as a key enabler of innovation in diagnostics, life sciences research, and biopharmaceutical development.

Industrial Impact

The global nucleic acid sample preparation instruments market has witnessed a substantial industrial impact, driven by the increasing integration of advanced sample preparation technologies across diagnostics, life sciences research, and biopharmaceutical manufacturing. As nucleic acid extraction and purification form the backbone of molecular workflows, industries are rapidly adopting automated instruments to enhance operational efficiency, ensure data accuracy, and support large-scale processing requirements. This shift is enabling laboratories and companies to streamline workflows, reduce turnaround times, and minimize manual errors, ultimately improving productivity and cost-effectiveness.

In the pharmaceutical and biotechnology sectors, these instruments have become indispensable for drug discovery, genomic research, and clinical trials. The rising focus on precision medicine and targeted therapies has significantly increased the demand for high-quality nucleic acid samples, directly impacting the adoption of advanced preparation systems. Additionally, the growing use of next-generation sequencing (NGS), liquid biopsy, and biomarker analysis has further strengthened the reliance on automated and high-throughput solutions, creating new growth avenues for instrument manufacturers.

The diagnostics industry has also experienced a notable transformation, as clinical laboratories increasingly incorporate automated nucleic acid preparation systems to manage high testing volumes and maintain consistent results. This has been particularly evident in infectious disease testing and oncology diagnostics, where rapid and reliable sample processing is critical. The industrial shift toward integrated, sample-to-result platforms is further enhancing laboratory capabilities and enabling decentralized testing models.

Moreover, the market is influencing the broader laboratory automation ecosystem, encouraging the development of complementary technologies such as robotic liquid handling systems, microfluidic platforms, and AI-driven data management tools. Manufacturers are focusing on innovation, strategic collaborations, and product differentiation to meet evolving industry needs. As a result, the nucleic acid sample preparation instruments market is not only supporting advancements in healthcare and research but also reshaping industrial practices by promoting automation, scalability, and technological integration across the life sciences value chain.

Market Segmentation:

Segmentation 1: By Product Type

  • Nucleic Acid Extraction Systems
  • Sample Disruption and Homogenization Instruments
  • Liquid Handling and Automation Systems

Nucleic Acid Extraction Systems Segment to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Product Type)

The nucleic acid extraction systems segment is expected to dominate the nucleic acid sample preparation instruments market by product type, owing to its fundamental role in isolating high-quality DNA and RNA required for downstream molecular applications. These systems represent the first and most critical step in workflows such as PCR, next-generation sequencing (NGS), and gene expression analysis, making them indispensable across clinical diagnostics, research laboratories, and pharmaceutical and biotechnology industries.

The dominance of this segment is largely driven by the increasing demand for automated and high-throughput extraction solutions that ensure accuracy, reproducibility, and contamination-free processing. With the rising prevalence of infectious diseases, cancer, and genetic disorders, laboratories are prioritizing reliable extraction systems capable of handling diverse sample types, including blood, tissue, and saliva. Additionally, advancements in technologies such as magnetic bead-based extraction and automated purification platforms have significantly improved efficiency and reduced manual intervention, further boosting adoption.

Moreover, the expansion of molecular diagnostics and genomics research has amplified the need for scalable extraction systems that can support large sample volumes without compromising quality. Pharmaceutical and biotechnology companies are also contributing to segment growth through extensive use of these systems in drug discovery, biomarker identification, and clinical trials. As laboratories continue to transition toward integrated and automated workflows, nucleic acid extraction systems are expected to maintain their leading position, driven by their critical importance in ensuring the reliability and success of downstream analytical processes.

Segmentation 2: By Technology

  • Automated Spin-Column based
  • Magnetic Bead-Based
  • Automated Liquid Handling

Magnetic Bead-Based to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Technology)

Magnetic bead-based technology is expected to dominate the nucleic acid sample preparation instruments market by technology, owing to its superior efficiency, scalability, and compatibility with automated workflows. This method has become the preferred choice for nucleic acid extraction and purification due to its ability to deliver high yield and purity of DNA and RNA across a wide range of sample types, including blood, tissue, and complex biological fluids.

The growing demand for high-throughput and contamination-free processing in molecular diagnostics and genomics research is a key factor driving the adoption of magnetic bead-based systems. Unlike traditional column-based or manual extraction techniques, magnetic bead technology enables seamless automation, reduces hands-on time, and minimizes the risk of cross-contamination, making it highly suitable for clinical laboratories and large-scale testing environments. This is particularly important in applications such as next-generation sequencing (NGS), PCR, and minimal residual disease (MRD) testing, where precision and reproducibility are critical.

Additionally, the flexibility of magnetic bead-based protocols allows for easy integration into robotic liquid handling systems and fully automated platforms, further enhancing laboratory efficiency. Pharmaceutical and biotechnology companies are increasingly utilizing this technology in drug discovery, biomarker research, and clinical trials, contributing to its widespread adoption. Continuous advancements in bead chemistry and automation capabilities are further improving performance and expanding application areas.

As laboratories continue to prioritize speed, accuracy, and scalability, magnetic bead-based technology is expected to maintain its leading position in the market, supported by its strong alignment with the ongoing shift toward automation and advanced molecular workflows.

Segmentation 3: By Throughput

  • Low-Throughput Instruments
  • Medium-Throughput Instruments
  • High-Throughput Instruments

Medium-Throughput Instruments to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Throughput)

Medium-throughput instruments are expected to dominate the nucleic acid sample preparation instruments market by throughput, as they offer an optimal balance among processing capacity, cost-efficiency, and operational flexibility. These systems are particularly well-suited for mid-sized laboratories, diagnostic centers, and research facilities that require consistent sample processing without the high capital investment associated with large-scale, high-throughput platforms.

The dominance of this segment is driven by the growing demand for efficient yet scalable solutions in molecular diagnostics, especially for applications such as infectious disease testing, oncology diagnostics, and genetic analysis. Medium throughput instruments typically support moderate sample volumes, making them ideal for routine laboratory workflows where accuracy, reproducibility, and turnaround time are critical. Their ability to handle varying sample loads without compromising performance makes them a preferred choice across diverse end users.

Additionally, the increasing adoption of automation in laboratories is boosting demand for medium-throughput systems, as they often come equipped with user-friendly interfaces, integrated protocols, and compatibility with advanced extraction technologies such as magnetic bead-based methods. These features help reduce manual intervention, minimize errors, and improve overall laboratory productivity.

Pharmaceutical and biotechnology companies, along with academic and research institutes, are also contributing to the growth of this segment by utilizing medium-throughput instruments for applications such as drug discovery, biomarker research, and clinical trial sample processing. As laboratories continue to seek cost-effective and versatile solutions that adapt to evolving testing needs, medium-throughput instruments are expected to maintain their leading position in the market.

Segmentation 4: By End User

  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostic Centers
  • Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
  • Contract Research Organizations

Academic Research Institutes to Dominate the Nucleic Acid Sample Preparation Instruments Market (by End User)

Academic research institutes are expected to dominate the nucleic acid sample preparation instruments market by end user, driven by their extensive involvement in genomics research, molecular biology studies, and early-stage scientific discovery. These institutions serve as key hubs for innovation, where nucleic acid extraction and purification are fundamental to a wide range of applications, including gene expression analysis, next-generation sequencing (NGS), and functional genomics.

The strong presence of government and private funding for life sciences research has significantly contributed to the growth of this segment. Universities and research centers are increasingly investing in advanced laboratory infrastructure, including automated nucleic acid sample preparation instruments, to enhance research efficiency and ensure high-quality, reproducible results. Additionally, the growing focus on areas such as cancer research, infectious diseases, and genetic disorders has amplified the demand for reliable sample preparation technologies within academic settings.

Academic institutes also play a crucial role in large-scale collaborative projects and consortium-based research, which often require processing high volumes of biological samples. This drives the adoption of both medium- and high-throughput instruments capable of supporting diverse and complex workflows. Furthermore, partnerships between academic institutions and pharmaceutical or biotechnology companies are fostering technology transfer and accelerating the adoption of advanced nucleic acid preparation solutions.

With continuous advancements in genomics and increasing emphasis on precision medicine, academic research institutes are expected to remain a dominant end-user segment, contributing significantly to market growth through sustained research activities, innovation, and demand for cutting-edge laboratory technologies.

Segmentation 5: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Portugal
    • Russia
    • Rest-of-Europe
  • Asia-Pacific
    • Australia
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Thailand
    • Taiwan
    • Singapore
    • Indonesia
    • Philippines
    • Rest-of-Asia-Pacific
  • Latin America
    • Argentina
    • Brazil
    • Chile
    • Mexico
    • Colombia
    • Rest-of-Latin America
  • Middle East and Africa
    • KSA
    • U.A.E.
    • South Africa
    • Rest-of-Middle East and Africa

North America to Dominate the Nucleic Acid Sample Preparation Instruments Market (by Region)

North America is expected to dominate the nucleic acid sample preparation instruments market by region, driven by its well-established healthcare infrastructure, strong presence of leading biotechnology and pharmaceutical companies, and high adoption of advanced molecular diagnostic technologies. The region, particularly the United States, serves as a global hub for genomics research and precision medicine, significantly contributing to the demand for efficient and automated nucleic acid preparation systems.

A key factor supporting regional dominance is the substantial investment in research and development activities by both government bodies and private organizations. Funding from agencies such as the National Institutes of Health (NIH), along with continuous innovation by industry players, has accelerated the adoption of advanced laboratory automation solutions. Additionally, the increasing prevalence of chronic diseases, cancer, and infectious diseases has further boosted the need for reliable molecular testing, thereby driving demand for nucleic acid sample preparation instruments.

North America also benefits from the early adoption of cutting-edge technologies, including next-generation sequencing (NGS), PCR-based diagnostics, and automated liquid handling systems. The presence of major market players and frequent product launches, collaborations, and strategic partnerships further strengthens the region's leadership position. Moreover, the growing focus on personalized medicine and biomarker-based therapies is increasing the reliance on high-quality nucleic acid extraction and purification processes.

Furthermore, the region's robust clinical and research ecosystem, comprising academic institutions, diagnostic laboratories, and biopharmaceutical companies, ensures sustained demand for these instruments. Favorable regulatory frameworks and a strong emphasis on quality and standardization also contribute to widespread adoption. As a result, North America is expected to maintain its dominance in the global nucleic acid sample preparation instruments market over the forecast period.

Recent Developments in the Nucleic Acid Sample Preparation Instruments Market

  • In October 2025, AutoGen, Inc. partnered with Sampled to deliver next-generation nucleic acid extraction and multi-omic workflows. Under the agreement, Sampled refers complex extraction projects to AutoGen; AutoGen refers large-scale extraction and downstream analysis to Sampled's integrated laboratory services.
  • In April 2025, QIAGEN N.V. announced plans to launch three new sample preparation instruments (QIAsymphony Connect, QIAsprint, QIAmini) in 2025-2026 to improve automation and efficiency across lab segments.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Rising Demand for Molecular Diagnostics and Genomic Testing: This market for nucleic acid sample preparation instruments is driven by the shift toward molecular testing. To meet the growing demand for molecular testing, public health and clinical laboratories are giving priority to acquiring automated and repeatable preparation platforms. As testing volumes continue to rise, instrument makers who concentrate on innovation in extraction efficiency, throughput, and integration with downstream workflows are well-positioned to gain a larger portion of the market.

Market Challenges:

High Cost of Instruments: The cost barrier is not merely a pricing issue but a market access challenge that influences purchasing decisions across public and private health systems. To broaden the uptake of nucleic acid sample preparation technologies, instrument manufacturers may need to develop innovative price strategies, modular system alternatives, or finance collaborations, especially for public health laboratories and low and middle-income regions. Latent demand could be unlocked by addressing affordability, the infrastructure for molecular testing could be modernised more quickly, and more equitable access to advanced diagnostics could be supported globally.

Market Opportunities:

Automation and Integrated Workflows: nucleic acid sample preparation instrument manufacturers would need to continue innovation and workflow integration to increase instrument adoption, especially in high-throughput, clinical, and research settings. As demand for molecular diagnostics continues to grow, platforms that deliver seamless, reproducible, and scalable preparation workflows will differentiate themselves by addressing critical laboratory challenges such as turnaround time, quality control, and operational cost efficiency.

How can this report add value to an organization?

Product/Innovation Strategy: The global nucleic acid sample preparation instruments market has been divided into several key segments, including product type, technology, Throughput, end users, and regional markets. By understanding which segments hold the largest share and which ones show potential for growth, this report offers invaluable insights for organizations looking to innovate and expand their product offerings.

Growth/Marketing Strategy: Strategic partnerships, collaborations, and business expansions are anticipated to be central to the growth of the nucleic acid sample preparation instruments market. Key developments and partnerships among diagnostic companies, healthcare providers, and research institutions have already begun to form a significant part of the market dynamics.

Competitive Strategy: The nucleic acid sample preparation instruments Market is highly competitive, with key players such as Thermo Fisher Scientific Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Danaher Corporation, and Agilent Technologies, Inc. leading through strong product portfolios and continuous innovation. Companies are focusing on automation, advanced extraction technologies, and strategic collaborations to enhance efficiency and expand their market presence, making the landscape dynamic and innovation-driven.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
  • The scope of the report is based on comprehensive inputs from industry experts across various sectors, including specialty clinics and hospitals, diagnostic laboratories, reference laboratories, and research institutions.
  • The market contribution of nucleic acid sample preparation instruments is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2024. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing nucleic acid sample preparation instruments, market products, and services. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts in the nucleic acid sample preparation instruments market, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • F. Hoffmann-La Roche AG
  • Promega Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • Eppendorf
  • Macherey-Nagel GmbH & Co. KG
  • Sage Science, Inc.
  • Hamilton Company
  • Revvity, Inc. (PerkinElmer, Inc.)
  • AutoGen Inc.
  • Hain Lifescience GmbH / BRUKER
  • bioMerieux, Inc.
  • Aurora Biomed Inc.
  • Genetic Signatures
  • Bioteke Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview and Ecosystem
  • 1.2 Market Attractiveness: Macro and Micro Factor Analysis
  • 1.3 Regulatory Outlook
  • 1.4 Pricing Analysis

2 Global Nucleic Acid Sample Preparation Instruments Market Overview

  • 2.1 Business Dynamics
    • 2.1.1 Impact Analysis
    • 2.1.2 Market Drivers
      • 2.1.2.1 Rising Demand for Molecular Diagnostics and Genomic Testing
      • 2.1.2.2 High Prevalence of Infectious Diseases and Chronic Conditions
      • 2.1.2.3 Growth in Genomic Research and Personalized Medicine
    • 2.1.3 Market Restraints
      • 2.1.3.1 High Cost of Instruments
      • 2.1.3.2 Technical Complexity and Standardization
    • 2.1.4 Market Opportunities and Trends
      • 2.1.4.1 Opportunities
        • 2.1.4.1.1 Automation and Integrated Workflows
        • 2.1.4.1.2 Growth in Emerging Markets
      • 2.1.4.2 Trends
        • 2.1.4.2.1 Shift toward Magnetic Bead-Based Technology
        • 2.1.4.2.2 Higher Throughput Demand in Clinical Labs

3 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by Product Type

  • 3.1 Overview
  • 3.2 Growth-Share Matrix
  • 3.3 Nucleic Acid Extraction Systems
  • 3.4 Sample Disruption and Homogenization Instruments
  • 3.5 Liquid Handling and Automation Systems

4 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by Technology

  • 4.1 Overview
  • 4.2 Growth-Share Matrix
  • 4.3 Automated Spin-Column based
  • 4.4 Magnetic Bead Based Throughput
  • 4.5 Automated Liquid Handling

5 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by Throughput

  • 5.1 Overview
  • 5.2 Growth-Share Matrix
  • 5.3 Low-Throughput Instruments
  • 5.4 Medium-Throughput Instruments
  • 5.5 High-Throughput Instruments

6 Global Nucleic Acid Sample Preparation Instruments Market, 2024-2035, by End User

  • 6.1 Overview
  • 6.2 Growth-Share Matrix
  • 6.3 Academic Research Institute
  • 6.4 Pharmaceutical and Biotechnology Companies
  • 6.5 Clinical Diagnostic Centers
  • 6.6 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
  • 6.7 Contract Research Organizations

7 Region

  • 7.1 Regional Summary
  • 7.2 North America
    • 7.2.1 Regional Overview
    • 7.2.2 Driving Factors for Market Growth
    • 7.2.3 Factors Challenging the Market
    • 7.2.4 By Country
      • 7.2.4.1 U.S.
      • 7.2.4.2 Canada
  • 7.3 Europe
    • 7.3.1 Regional Overview
    • 7.3.2 Driving Factors for Market Growth
    • 7.3.3 Factors Challenging the Market
    • 7.3.4 By Country
      • 7.3.4.1 Germany
      • 7.3.4.2 U.K.
      • 7.3.4.3 France
      • 7.3.4.4 Italy
      • 7.3.4.5 Spain
      • 7.3.4.6 Netherlands
      • 7.3.4.7 Poland
      • 7.3.4.8 Portugal
      • 7.3.4.9 Russia
      • 7.3.4.10 Rest-of-Europe
  • 7.4 Asia Pacific
    • 7.4.1 Regional Overview
    • 7.4.2 Driving Factors for Market Growth
    • 7.4.3 Factors Challenging the Market
    • 7.4.4 By Country
      • 7.4.4.1 Australia
      • 7.4.4.2 China
      • 7.4.4.3 India
      • 7.4.4.4 Japan
      • 7.4.4.5 Malaysia
      • 7.4.4.6 South Korea
      • 7.4.4.7 Thailand
      • 7.4.4.8 Taiwan
      • 7.4.4.9 Singapore
      • 7.4.4.10 Indonesia
      • 7.4.4.11 Philippines
      • 7.4.4.12 Rest-of-Asia-Pacific
  • 7.5 Latin America
    • 7.5.1 Regional Overview
    • 7.5.2 Driving Factors for Market Growth
    • 7.5.3 Factors Challenging the Market
    • 7.5.4 By Country
      • 7.5.4.1 Argentina
      • 7.5.4.2 Brazil
      • 7.5.4.3 Chile
      • 7.5.4.4 Mexico
      • 7.5.4.5 Colombia
      • 7.5.4.6 Rest-of-Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Regional Overview
    • 7.6.2 Driving Factors for Market Growth
    • 7.6.3 Factors Challenging the Market
    • 7.6.4 By Country
      • 7.6.4.1 Saudi Arabia
      • 7.6.4.2 South Africa
      • 7.6.4.3 U.A.E.
      • 7.6.4.4 Rest of the Middle East and Africa

8 Markets - Competitive Benchmarking & Company Profiles

  • 8.1 Product Benchmarking
  • 8.2 Key Strategies and Developments (by Company)
    • 8.2.1 Partnerships, Collaborations, and Business Expansions
    • 8.2.2 New Offerings
  • 8.3 Company Share Analysis
  • 8.4 Company Profiles
    • 8.4.1 F. Hoffmann-La Roche AG
      • 8.4.1.1 Overview
      • 8.4.1.2 Top Products/Product Portfolio
      • 8.4.1.3 Top Competitors
      • 8.4.1.4 Target Customers
      • 8.4.1.5 Key Personal
      • 8.4.1.6 Analyst View
    • 8.4.2 Promega Corporation
      • 8.4.2.1 Overview
      • 8.4.2.2 Top Products/Product Portfolio
      • 8.4.2.3 Top Competitors
      • 8.4.2.4 Target Customers
      • 8.4.2.5 Key Personal
      • 8.4.2.6 Analyst View
    • 8.4.3 QIAGEN N.V.
      • 8.4.3.1 Overview
      • 8.4.3.2 Top Products/Product Portfolio
      • 8.4.3.3 Top Competitors
      • 8.4.3.4 Target Customers
      • 8.4.3.5 Key Personal
      • 8.4.3.6 Analyst View
    • 8.4.4 Thermo Fisher Scientific Inc.
      • 8.4.4.1 Overview
      • 8.4.4.2 Top Products/Product Portfolio
      • 8.4.4.3 Top Competitors
      • 8.4.4.4 Target Customers
      • 8.4.4.5 Key Personal
      • 8.4.4.6 Analyst View
    • 8.4.5 Tecan Trading AG
      • 8.4.5.1 Overview
      • 8.4.5.2 Top Products/Product Portfolio
      • 8.4.5.3 Top Competitors
      • 8.4.5.4 Target Customers
      • 8.4.5.5 Key Personal
      • 8.4.5.6 Analyst View
    • 8.4.6 Eppendorf
      • 8.4.6.1 Overview
      • 8.4.6.2 Top Products/Product Portfolio
      • 8.4.6.3 Top Competitors
      • 8.4.6.4 Target Customers
      • 8.4.6.5 Key Personal
      • 8.4.6.6 Analyst View
    • 8.4.7 Macherey-Nagel GmbH & Co. KG
      • 8.4.7.1 Overview
      • 8.4.7.2 Top Products/Product Portfolio
      • 8.4.7.3 Top Competitors
      • 8.4.7.4 Target Customers
      • 8.4.7.5 Key Personal
      • 8.4.7.6 Analyst View
    • 8.4.8 Sage Science, Inc.
      • 8.4.8.1 Overview
      • 8.4.8.2 Top Products/Product Portfolio
      • 8.4.8.3 Top Competitors
      • 8.4.8.4 Target Customers
      • 8.4.8.5 Key Personal
      • 8.4.8.6 Analyst View
    • 8.4.9 Hamilton Company
      • 8.4.9.1 Overview
      • 8.4.9.2 Top Products/Product Portfolio
      • 8.4.9.3 Top Competitors
      • 8.4.9.4 Target Customers
      • 8.4.9.5 Key Personal
      • 8.4.9.6 Analyst View
    • 8.4.10 Revvity, Inc. (PerkinElmer, Inc.)
      • 8.4.10.1 Overview
      • 8.4.10.2 Top Products/Product Portfolio
      • 8.4.10.3 Top Competitors
      • 8.4.10.4 Target Customers
      • 8.4.10.5 Key Personal
      • 8.4.10.6 Analyst View
    • 8.4.11 AutoGen Inc.
      • 8.4.11.1 Overview
      • 8.4.11.2 Top Products/Product Portfolio
      • 8.4.11.3 Top Competitors
      • 8.4.11.4 Target Customers
      • 8.4.11.5 Key Personal
      • 8.4.11.6 Analyst View
    • 8.4.12 Hain Lifescience GmbH/BRUKER
      • 8.4.12.1 Overview
      • 8.4.12.2 Top Products/Product Portfolio
      • 8.4.12.3 Top Competitors
      • 8.4.12.4 Target Customers
      • 8.4.12.5 Key Personal
      • 8.4.12.6 Analyst View
    • 8.4.13 bioMerieux, Inc
      • 8.4.13.1 Overview
      • 8.4.13.2 Top Products/Product Portfolio
      • 8.4.13.3 Top Competitors
      • 8.4.13.4 Target Customers
      • 8.4.13.5 Key Personnel
      • 8.4.13.6 Analyst View
    • 8.4.14 Aurora Biomed Inc.
      • 8.4.14.1 Overview
      • 8.4.14.2 Top Products/Product Portfolio
      • 8.4.14.3 Top Competitors
      • 8.4.14.4 Target Customers
      • 8.4.14.5 Key Personnel
      • 8.4.14.6 Analyst View
    • 8.4.15 Genetic Signatures
      • 8.4.15.1 Overview
      • 8.4.15.2 Top Products/Product Portfolio
      • 8.4.15.3 Top Competitors
      • 8.4.15.4 Target Customers
      • 8.4.15.5 Key Personnel
      • 8.4.15.6 Analyst View
    • 8.4.16 Bioteke Corporation
      • 8.4.16.1 Overview
      • 8.4.16.2 Top Products/Product Portfolio
      • 8.4.16.3 Top Competitors
      • 8.4.16.4 Target Customers
      • 8.4.16.5 Key Personnel
      • 8.4.16.6 Analyst View

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Data Triangulation
  • 9.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Nucleic Acid Sample Preparation Instruments Market (by Scenario), $Million, 2024, 2030, and 2035
  • Figure 2: Global Nucleic Acid Sample Preparation Instruments Market (by Region), $Million, 2024, 2030, and 2035
  • Figure 3: Global Nucleic Acid Sample Preparation Instruments Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 4: Global Nucleic Acid Sample Preparation Instruments Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 5: Global Nucleic Acid Sample Preparation Instruments Market (by Throughput), $Million, 2024, 2030, and 2035
  • Figure 6: Global Nucleic Acid Sample Preparation Instruments Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 7: Global Nucleic Acid Sample Preparation Instruments Market, $Million, 2018-2035
  • Figure 8: Regional Estimate of Tuberculosis Incidence, Thousands, 2023
  • Figure 9: Global Nucleic Acid Sample Preparation Instruments Market (by Product Type), $Million, 2024, 2030, and 2035
  • Figure 10: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by Product Type), 2024-2035
  • Figure 11: Global Nucleic Acid Sample Preparation Instruments Market (Nucleic Acid Extraction Systems), $Million, 2024-2035
  • Figure 12: Global Nucleic Acid Sample Preparation Instruments Market (Nucleic Acid Extraction Systems), Units, 2024-2035
  • Figure 13: Global Nucleic Acid Sample Preparation Instruments Market (Sample Disruption and Homogenization Instruments), $Million, 2024-2035
  • Figure 14: Global Nucleic Acid Sample Preparation Instruments Market (Sample Disruption and Homogenization Instruments), Units, 2024-2035
  • Figure 15: Global Nucleic Acid Sample Preparation Instruments Market (Liquid Handling and Automation Systems), $Million, 2024-2035
  • Figure 16: Global Nucleic Acid Sample Preparation Instruments Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 17: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by Technology), 2024-2035
  • Figure 18: Global Nucleic Acid Sample Preparation Instruments Market (Automated Spin-Column based), $Million, 2024-2035
  • Figure 19: Global Nucleic Acid Sample Preparation Instruments Market (Automated Spin-Column based), Units, 2024-2035
  • Figure 20: Global Nucleic Acid Sample Preparation Instruments Market (Magnetic Bead Based), $Million, 2024-2035
  • Figure 21: Global Nucleic Acid Sample Preparation Instruments Market (Magnetic Bead Based), Units, 2024-2035
  • Figure 22: Global Nucleic Acid Sample Preparation Instruments Market (Automated Liquid Handling), $Million, 2024-2035
  • Figure 23: Global Nucleic Acid Sample Preparation Instruments Market (by Throughput), $Million, 2024, 2030, and 2035
  • Figure 24: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by Throughput), 2024-2035
  • Figure 25: Global Nucleic Acid Sample Preparation Instruments Market (Low-Throughput Instruments), $Million, 2024-2035
  • Figure 26: Global Nucleic Acid Sample Preparation Instruments Market (Low-Throughput Instruments), Units, 2024-2035
  • Figure 27: Global Nucleic Acid Sample Preparation Instruments Market (Medium-Throughput Instruments), $Million, 2024-2035
  • Figure 28: Global Nucleic Acid Sample Preparation Instruments Market (Medium-Throughput Instruments), Units, 2024-2035
  • Figure 29: Global Nucleic Acid Sample Preparation Instruments Market (High-Throughput Instruments), $Million, 2024-2035
  • Figure 30: Global Nucleic Acid Sample Preparation Instruments Market (High-Throughput Instruments), Units, 2024-2035
  • Figure 31: Global Nucleic Acid Sample Preparation Instruments Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 32: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Instruments Market (by End User), 2024-2035
  • Figure 33: Global Nucleic Acid Sample Preparation Instruments Market (Academic Research Institute), $Million, 2024-2035
  • Figure 34: Global Nucleic Acid Sample Preparation Instruments Market (Academic Research Institute), Units, 2024-2035
  • Figure 35: Global Nucleic Acid Sample Preparation Instruments Market (Pharmaceutical and Biotechnology Companies), $Million, 2024-2035
  • Figure 36: Global Nucleic Acid Sample Preparation Instruments Market (Pharmaceutical and Biotechnology Companies), Units, 2024-2035
  • Figure 37: Global Nucleic Acid Sample Preparation Instruments Market (Clinical Diagnostic Centers), $Million, 2024-2035
  • Figure 38: Global Nucleic Acid Sample Preparation Instruments Market (Clinical Diagnostic Centers), Units, 2024-2035
  • Figure 39: Global Nucleic Acid Sample Preparation Instruments Market (Applied Testing (Biobanks, Forensic and Veterinary Laboratories)), $Million, 2024-2035
  • Figure 40: Global Nucleic Acid Sample Preparation Instruments Market (Applied Testing (Biobanks, Forensic and Veterinary Laboratories)), Units, 2024-2035
  • Figure 41: Global Nucleic Acid Sample Preparation Instruments Market (Contract Research Organizations), $Million, 2024-2035
  • Figure 42: Global Nucleic Acid Sample Preparation Instruments Market (Contract Research Organizations), Units, 2024-2035
  • Figure 43: North America Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 44: U.S. Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 45: Canada Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 46: Europe Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 47: Germany Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 48: U.K. Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 49: France Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 50: Italy Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 51: Spain Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 52: Netherlands Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 53: Poland Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 54: Portugal Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 55: Russia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 56: Rest-of-Europe Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 57: Asia Pacific Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 58: Australia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 59: China Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 60: India Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 61: Japan Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 62: Malaysia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 63: South Korea Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 64: Thailand Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 65: Taiwan Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 66: Singapore Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 67: Indonesia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 68: Philippines Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 69: Rest-of-Asia-Pacific Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 70: Latin America Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 71: Argentina Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 72: Brazil Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 73: Chile Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 74: Mexico Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 75: Colombia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 76: Rest-of-Latin America Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 77: Middle East and Africa Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 78: Saudi Arabia Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 79: South Africa Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 80: U.A.E Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 81: Rest-of-Middle East and Africa Nucleic Acid Sample Preparation Instruments Market, $Million, 2024-2035
  • Figure 82: Company Share Analysis, Nucleic Acid Sample Preparation Instruments (Nucleic Acid Extraction Systems and Sample Disruption and Homogenization Instruments) Market
  • Figure 83: Data Triangulation
  • Figure 84: Top-Down and Bottom-Up Approach
  • Figure 85: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Nucleic Acid Sample Preparation Instruments Market, Market Attractiveness
  • Table 3: Global Nucleic Acid Sample Preparation Instruments Market Regulatory Landscape in the U.S., EU, Japan, China, and India
  • Table 4: Pricing of Nucleic Acid Sample Preparation Instruments by Product (Nucleic Acid Extraction Systems)
  • Table 5: Pricing of Nucleic Acid Sample Preparation Instruments by Product (Liquid Handling and Automation Systems)
  • Table 6: Pricing of Nucleic Acid Sample Preparation Instruments by Product (Sample Disruption & Homogenization Instruments)
  • Table 7: Impact Analysis of Market Dynamics, 2024-2035
  • Table 8: Low-Throughput Instruments
  • Table 9: Medium-Throughput Instruments
  • Table 10: High-Throughput Instruments
  • Table 11: Global Nucleic Acid Sample Preparation Instruments Market (by Region), $Million, 2024-2035
  • Table 12: Nucleic Acid Sample Preparation Instruments Market, Product Benchmarking (by Product Type)
  • Table 13: Partnerships, Collaborations, and Business Expansions
  • Table 14: New Offerings